$GCTS Balance Sheet | Understand Stock

$GCTS

$1.27 +$0.04 (3.25%) Close

$GCTS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Nov 8, 2021
Assets
Current assets:
Cash and cash equivalents
Prepaid expenses
Expense reimbursement receivable from GCT
Accounts receivable, net
Inventory
Contract assets
Prepaid expenses and other current assets
Total current assets
Long-term prepaid expenses
Marketable securities and cash held in trust account
Property and equipment, net
Operating lease right-of-use assets
Intangibles, net
Other assets
Total assets

Liabilities and Stockholders' Deficit
Current liabilities:
Taxes payable
Due to related party
Accrued income taxes
Accounts payable and accrued expenses
Accrued legal expense
Accrued capital markets advisory expense
Other accounts payable and accrued expenses
Excise tax payable
Accounts payable
Contract liabilities
Accrued and other current liabilities
Common stock forward liability
Borrowings
Convertible promissory notes, current
Operating lease liabilities, current
Total current liabilities

Deferred underwriting fee payable
Warrant liability, at fair value
Long-term borrowings
Convertible promissory notes, net of current
Net defined benefit liabilities
Long-term operating lease liabilities
Other taxes payable
Warrant liabilities
Other liabilities
Sponsor loans, at fair value
Deferred underwriters' discount
Deferred underwriters' commission
Total liabilities
Common stock subject to possible redemption, 3,941,361 and 34,500,000 shares at redemption value of $10.76 and $10.31 at December 31, 2023 and 2022, respectively
Class A common stock
Class A common stock subject to possible redemption
Total class A common stock

Total common stock subject to possible redemption, 3,941,361 and 34,500,000 shares at redemption value of $10.76 and $10.31 at December 31, 2023 and 2022, respectively

Stockholders' deficit:
Common stock, par value $0.0001 per share; 400,000 shares authorized as of June 30, 2026 and December 31, 2025; 91,964 and 58,137 shares issued and outstanding as of 91,964, 2026 and December 31, 2025, respectively
Class A common stock
Class A common stock not subject to possible redemption
Total class A common stock

Class B common stock
Total common stock, par value $0.0001 per share; 400,000 shares authorized as of June 30, 2026 and December 31, 2025; 91,964 and 58,137 shares issued and outstanding as of 91,964, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders' deficit
Total liabilities and stockholders' deficit

Comments